AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 53 filers reported holding AGILE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $171,000 | -75.8% | 350,000 | -52.4% | 0.02% | -77.7% |
| Q3 2021 | $706,000 | -27.8% | 735,000 | 0.0% | 0.09% | -34.3% |
| Q2 2021 | $978,000 | -36.0% | 735,000 | 0.0% | 0.14% | -31.6% |
| Q1 2021 | $1,529,000 | -11.2% | 735,000 | +22.5% | 0.21% | -27.7% |
| Q4 2020 | $1,722,000 | +2549.2% | 600,000 | +990.9% | 0.29% | +1276.2% |
| Q3 2019 | $65,000 | -53.2% | 55,000 | -42.1% | 0.02% | -54.3% |
| Q2 2019 | $139,000 | -42.6% | 95,000 | -40.6% | 0.05% | -43.9% |
| Q1 2019 | $242,000 | +426.1% | 160,000 | +100.0% | 0.08% | +382.4% |
| Q4 2018 | $46,000 | -45.9% | 80,000 | -65.3% | 0.02% | -34.6% |
| Q3 2018 | $85,000 | -29.8% | 230,375 | -6.5% | 0.03% | -23.5% |
| Q2 2018 | $121,000 | -89.0% | 246,325 | -42.4% | 0.03% | -89.2% |
| Q1 2018 | $1,099,000 | 0.0% | 427,544 | +4.6% | 0.31% | +7.5% |
| Q4 2017 | $1,099,000 | -51.1% | 408,838 | -18.8% | 0.29% | -48.7% |
| Q3 2017 | $2,246,000 | +39.2% | 503,538 | +17.1% | 0.57% | +32.6% |
| Q2 2017 | $1,613,000 | +122.5% | 430,000 | +90.1% | 0.43% | +129.4% |
| Q1 2017 | $725,000 | -9.3% | 226,138 | +61.5% | 0.19% | -8.3% |
| Q4 2016 | $799,000 | +154.5% | 140,000 | +211.1% | 0.20% | +145.8% |
| Q3 2016 | $314,000 | – | 45,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|